The Patent Finder

U3 Pharma GmbH

Also on record
Records under this name other than patents U3 Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to U3 Pharma GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,100,124Antibodies Directed to HER-3 and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,988,462Material and Methods for Treating or Preventing HER-3 Associated Diseases
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,705,130Antibodies Directed to HER-3 and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,249,230Antibodies Directed to HER-3 and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,803,025Material and Methods for Treating or Preventing HER-3 Associated Diseases
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,365,283Activated HER3 as a marker for predicting therapeutic efficacy
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,771,695Antibodies directed to HER-3 and uses thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,828,382Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,101,760Material and Methods for Treating or Preventing HER-3 Associated Diseases
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,357,566HER3 inhibitor for modulating radiosensitivity
Formerly held
In force
 · USPTO record
In forceUSPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited